1
|
Alsolami E, Alobaidi S. Hemodialysis nurses' knowledge, attitude, and practices in managing vascular access: A cross-sectional study in Saudi Arabia. Medicine (Baltimore) 2024; 103:e37310. [PMID: 38552067 PMCID: PMC10977577 DOI: 10.1097/md.0000000000037310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 01/29/2024] [Indexed: 04/02/2024] Open
Abstract
Hemodialysis continues to be the primary approach for renal replacement therapy. Vascular access (VA), particularly arteriovenous fistula or arteriovenous graft, is the preferred technique for establishing hemodialysis access due to its lower risk of infection and central venous stenosis compared to catheters. The aim of this cross-sectional investigation was to examine hemodialysis nurses' knowledge, confidence, and practices in managing VA in Saudi Arabia. This is an online cross-sectional survey study that was conducted in Saudi Arabia between June and August 2023. This study utilized a previously validated questionnaire. Examined dialysis nurses' knowledge, attitude, practice, and self-efficacy pertaining to VA cannulation and evaluation. Binary logistic regression analysis was used to identify predictors of better knowledge of dialysis VA. A total of 197 participants were involved in this study. Around one-third of the study participants (37.0%) reported that they have received specialized training in managing VA. Participants agreement (answered agree or strongly agree) on statements that examined attitudes toward dialysis VA cannulation and management was high and ranged between 75.0% and 93.0%. The majority of participants (97.5%) reported that they perform this assessment. Most nurses (65%) preferred the rope-ladder technique. Participants agreement on statements that examined self-efficacy on dialysis VA cannulation and management was high and ranged between 72.1% and 98.0%. The most commonly agreed upon statement was that "they have confident in performing hemodialysis access (arteriovenous fistula and arteriovenous graft) assessment before cannulation." With 98.0% (answered agree and strongly agree). The mean knowledge score for our study sample was 6.4 (SD: 2.0) out of 12 (53.3%); which reflects marginal-level of knowledge on dialysis VA. Binary logistic regression analysis identified that nurses who have undergraduate degree are 92% more likely to be knowledgeable on dialysis VA compared to others (P < .05). Concerning VA, the level of knowledge among hemodialysis nurses working in Saudi Arabia was inadequate. Nurses who hold an undergraduate degree are presumed to have a more extensive understanding of dialysis VA. Further education programs are necessary for HD nurses to enhance their knowledge of VA, thereby optimizing their professional practices and enhancing the outcomes for their patients.
Collapse
Affiliation(s)
- Enad Alsolami
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Sami Alobaidi
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia
| |
Collapse
|
2
|
Alfawaz M, Alkhiari R, Albuhayjani AA, Albarrak A, Alharbi MY, Aldubaiyan AAR, Alkharraz AH, Alolayan OA, Alrasheedi O, Almutairi N, Aljehani F, Alsolami E, Alghamdi W, Jawa H. Clinical Characteristics of Celiac Disease Patients in Qassim Region. J Family Med Prim Care 2024; 13:827-832. [PMID: 38736775 PMCID: PMC11086769 DOI: 10.4103/jfmpc.jfmpc_895_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 06/15/2023] [Accepted: 08/29/2023] [Indexed: 05/14/2024] Open
Abstract
Objective It is well known that celiac disease has a negative influence on patients' health and quality of life. It has a wide range of presentation from symptomless to multiple organ dysfunction but mainly gastrointestinal symptoms. Consequently, it is considered a main cause of mortality, morbidity, and health burden. We aim to evaluate the quality of life affected in gluten-free diet and to identify the serological characteristics of celiac disease patients in the Qassim Region of Saudi Arabia and King Fahad Specialist Hospital. Methods This is a cross-sectional-based study conducted in King Fahad Specialist Hospital, Saudi Arabia, composed of 58 patients with celiac disease for 9 years between August 2011 and August 2020. Results Fifty-eight patents were included (79.3% females and 65.5% married), who were divided according to their ages into five groups. Abdominal pain, diarrhea, and/or weight loss were the major patient complaints. A total of 64% of the patients had a +ve (tTG) IgA test at the time of diagnosis, while 17% were -ve. Of the studied patients, 78% reported that they had undergone a duodenal biopsy sampling. No other significant abnormalities were detected between females and males or among the five diagnosed age groups. Conclusion Patients with celiac disease reported poor health-related quality of life across the board. However, social interaction, emotional role functioning, and emotional well-being were the most important factors.
Collapse
Affiliation(s)
- Mohammed Alfawaz
- Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Resheed Alkhiari
- Department of Medicine, College of Medicine, Qassim University, Qassim, Saudi Arabia
| | | | - Abdulmajeed Albarrak
- Department of Medicine, College of Medicine, Qassim University, Qassim, Saudi Arabia
| | | | | | | | | | | | - Nawaf Almutairi
- Department of Medicine, King Fahd Specialist Hospital, Buraydah, Saudi Arabia
| | - Faisal Aljehani
- Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Enad Alsolami
- Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Waleed Alghamdi
- Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Hani Jawa
- Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| |
Collapse
|
3
|
Alaryni AA, Alrowaie F, Alghamdi A, Alabdullah R, Alnutaifi RA, Alajlan R, Alnutaifi RA, Aldakheelallah A, Alshabanat A, Bin Shulhub AS, Moazin OM, Qutob R, Alsolami E, Hakami OA. Assessment of Burden in Caregivers of Patients Undergoing Hemodialysis and Peritoneal Dialysis: A Cross-Sectional Study in Riyadh, Saudi Arabia. Cureus 2024; 16:e52513. [PMID: 38371074 PMCID: PMC10874250 DOI: 10.7759/cureus.52513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/05/2024] [Indexed: 02/20/2024] Open
Abstract
A caregiver attends to the needs or concerns of someone limited by disease, injury, or disability to enhance the patient's quality of life, which can be assessed in three areas: social, physical, and psychological. This cross-sectional study assessed the extent of burden experienced by the caregivers of patients undergoing hemodialysis (HD) and peritoneal dialysis (PD) therapy in King Fahad Medical City in Riyadh, Saudi Arabia. The Zarit Burden Interview Arabic Abridged version (ZBI-A) was used to assess the level of burden experienced by caregivers. The data was collected and examined by professionals using the SPSS version 23. Based on the data of 50 participants, a mean ZBI-12 score of 12.22 ± 7.2 was reported. According to the ZBI scale, "No to mild burden," "Mild to moderate burden," and "High burden" were reported as 46% (n = 23), 38% (n = 19), and 16% (n = 8) of participants, respectively. The internal consistency of the ZBI-12 scale, assessed using Cronbach's alpha, was 0.664, indicating a satisfactory level of internal consistency. It was determined that caregivers of individuals undergoing PD and HD encounter different degrees of burden, with a significant proportion of caregivers experiencing a substantial burden.
Collapse
Affiliation(s)
- Abdullah A Alaryni
- Internal Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | | | - Abdullah Alghamdi
- Internal Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Razan Alabdullah
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Raneem A Alnutaifi
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Renad Alajlan
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Raed A Alnutaifi
- College of Medicine, King Saud University Medical City, Riyadh, SAU
| | | | - Alanoud Alshabanat
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | | | - Othillah M Moazin
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Rayan Qutob
- Internal Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU
| | - Enad Alsolami
- Internal Medicine, University of Jeddah, Jeddah, SAU
| | | |
Collapse
|
4
|
Alsolami E, Lotfy K, Alkhunaizi A, Cuerden M, Weir MA, House AA. Impact of Donation After Circulatory Death on Outcomes of Expanded Criteria Donor Kidney Transplants. Transplant Proc 2024; 56:50-57. [PMID: 38199855 DOI: 10.1016/j.transproceed.2023.11.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Accepted: 11/26/2023] [Indexed: 01/12/2024]
Abstract
Expanded criteria donor (ECD) kidneys experience suboptimal outcomes compared with standard criteria donor kidneys. To examine the additional impact of deceased organ category, donation after circulatory death (DCD), and neurologic determination of death (NDD) on ECD outcomes, we examined 1- and 3-year patient and graft survival in all ECD kidney recipients in our institution between January 2008 and December 2017. Of 166 ECD recipients, 49 (29.5%) were DCD and 117 (70.5%) were NDD. Delayed graft function was higher in the DCD/ECD group 61.2 % vs 32.0 % among NDD/ECD recipients. Graft loss was significantly increased among DCD/ECD (hazard ratio for graft loss 4.81 [95% CI1.78-13.01], P = .002 at 1 year and 2.03 [95% CI 1.03-4.0], P = .042 at 3 years). Death-censored graft loss was higher among DCD/ECD (hazard ratio was 10.12 [95% CI, 2.14, 47.92], P = .004 at 1 year and 2.83 [95% CI, 1.24, 6.46], P = .014 at 3 years). There was no statistically significant difference in all-cause mortality. Our study demonstrated that DCD/ECD kidneys have lower graft survival compared with NDD/ECD kidneys. Time on dialysis, waiting time, and panel reactive antibody should be taken into account when offering these organs to patients.
Collapse
Affiliation(s)
- Enad Alsolami
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Khaled Lotfy
- Department of Medicine, Western University, London, Canada
| | - Ahd Alkhunaizi
- Department of Medicine, Western University, London, Canada
| | - Meaghan Cuerden
- Department of Epidemiology and Biostatistics, Western University, London, Canada
| | - Matthew A Weir
- Department of Medicine, Western University, London, Canada
| | - Andrew A House
- Department of Medicine, Western University, London, Canada.
| |
Collapse
|
5
|
AlRowaie F, Alaryni A, AlGhamdi A, Alajlan R, Alabdullah R, Alnutaifi R, Alnutaifi R, Aldakheelallah A, Alshabanat A, Bin Shulhub A, Moazin O, Qutob R, Alsolami E, Hakami O. Quality of Life among Peritoneal and Hemodialysis Patients: A Cross-Sectional Study. Clin Pract 2023; 13:1215-1226. [PMID: 37887085 PMCID: PMC10605737 DOI: 10.3390/clinpract13050109] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 09/16/2023] [Accepted: 09/25/2023] [Indexed: 10/28/2023] Open
Abstract
BACKGROUND The quality of life (QoL) of patients with end-stage kidney disease (ESKD) who undergo dialysis is a reliable predictor of their long-term survival. Hemodialysis is the most common form of kidney replacement therapy for ESKD, followed by peritoneal dialysis. This study aimed to identify the factors affecting QoL in ESKD patients treated with peritoneal dialysis (PD) or hemodialysis (HD) in Riyadh, Saudi Arabia. METHODS A cross-sectional study was conducted between June and July 2021 to assess the QoL of patients with ESKD who underwent peritoneal dialysis and hemodialysis. Patients who had been on dialysis for at least one year were included. The Arabic version of the Quality of Life Index-Dialysis (QLI-D) version III was used to measure the QoL. RESULTS A total of 210 patients completed the questionnaire. The overall QLI score was 21.73 ± 4.2, with subscales for health and functioning (20.35 ± 5.2), social and economic (20.20 ± 4.8), psychological/spiritual (23.94 ± 4.9), and family (24.95 ± 4.5). The QLI scores for PD and HD patients were 21.80 ± 4.4 and 21.72 ± 4.1, respectively. SOCSUB (p = 0.031) was significantly associated with group and income, whereas QLI (p = 0.003), HFSUB (p = 0.013), SOCSUB (p = 0.002), and PSPSUB (p = 0.003) were significantly correlated with group and years of dialysis. CONCLUSION The study found that patients were most satisfied with their family, health and functioning, and social/economic subscales. Income and years of dialysis were found to be predictive factors of QoL. Overall, peritoneal patients in this study demonstrated a better QoL than HD patients.
Collapse
Affiliation(s)
- Fadel AlRowaie
- Nephrology Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia;
| | - Abdullah Alaryni
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Abdullah AlGhamdi
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Renad Alajlan
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Razan Alabdullah
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Raed Alnutaifi
- College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia;
| | - Raneem Alnutaifi
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Amani Aldakheelallah
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Alanoud Alshabanat
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Abdullah Bin Shulhub
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Othillah Moazin
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Rayan Qutob
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| | - Enad Alsolami
- Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah P.O. Box 45311, Saudi Arabia;
| | - Osamah Hakami
- College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
| |
Collapse
|
6
|
Alsolami E. Intravenous Artesunate Treatment of Severe Malaria in a Patient With Systemic Lupus Erythematosus: A Case of Post-Artesunate Delayed Hemolysis. Cureus 2023; 15:e44201. [PMID: 37767260 PMCID: PMC10521586 DOI: 10.7759/cureus.44201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/27/2023] [Indexed: 09/29/2023] Open
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune condition linked to multi-organ damage, and its correlation with malaria has been theorized. This case report details a 14-year-old Sudanese girl diagnosed with SLE and severe malaria who experienced hemolytic anemia following intravenous artesunate treatment. Intravenous artesunate was administered as the recommended treatment for severe malaria for one week and led to prolonged hemolysis with low hemoglobin levels and elevated lactate dehydrogenase activity; over three weeks, the hemolysis gradually subsided. This case highlights the need to consider post-artesunate (or artemisinin) delayed hemolysis (PADH) as a potential complication among patients receiving artemisinin derivatives for malaria treatment, thus necessitating enhanced surveillance strategies and further investigation of its mechanisms to optimize clinical practice and patient outcomes in this population.
Collapse
Affiliation(s)
- Enad Alsolami
- Internal Medicine, College of Medicine, University of Jeddah, Jeddah, SAU
- Internal Medicine, Saudi German Hospital, Jeddah, SAU
| |
Collapse
|
7
|
Aljehani F, Qashqari MB, Alghamdi MK, Saadi AI, Alreasini MY, Alsolami E, Alfawaz M. Prevalence of Iatrogenic Vitamin D Toxicity Among the Saudi Population of Vitamin D Users Due to Overcorrection. Cureus 2023; 15:e37521. [PMID: 37193464 PMCID: PMC10182715 DOI: 10.7759/cureus.37521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/13/2023] [Indexed: 05/18/2023] Open
Abstract
Background Despite abundant sunlight exposure, vitamin D deficiency remains a major challenge in Saudi Arabia. Meanwhile, the widespread use of vitamin D supplements has prompted concerns about toxicity, which although rare, can have severe health consequences. Objective The objective of this cross-sectional study was to analyze the prevalence and associated factors of iatrogenic vitamin D toxicity among the Saudi population of vitamin D users due to overcorrection. Methods An online questionnaire was used to collect data from 1,677 participants across all regions of Saudi Arabia. The questionnaire included responses on the prescription, duration of vitamin D intake, dosage, frequency, history of vitamin D toxicity, symptom onset, and duration. Results One thousand six hundred and seventy-seven responses were included across all regions of Saudi Arabia. A majority of participants were female (66.7%) and around half were aged 18-25 years. A history of vitamin D use was reported by 63.8% of participants, and 48% were still using vitamin D supplements. Most participants (79.3%) consulted a physician, and 84.8% had taken a vitamin D test before using the supplement. Commonly reported motives for taking vitamin D included vitamin D deficiency (72.1%), lack of sun exposure (26.1%), and hair loss (20.6%). Symptoms of overdose were reported by 6.6% of participants, with 3.3% having an overdose and 2.1% experiencing both overdose and symptoms. Conclusion This study showed that although a large portion of the Saudi population is taking vitamin D supplements, the prevalence of vitamin D toxicity is relatively low. However, this prevalence should not be ignored, and further research is needed to understand the factors contributing to vitamin D toxicity in order to minimize its occurrence.
Collapse
Affiliation(s)
- Faisal Aljehani
- Internal Medicine, College of Medicine, University of Jeddah, Jeddah, SAU
| | | | | | - Abdalaziz I Saadi
- Internal Medicine, College of Medicine, University of Jeddah, Jeddah, SAU
| | | | - Enad Alsolami
- Internal Medicine, College of Medicine, University of Jeddah, Jeddah, SAU
| | - Mohammed Alfawaz
- Internal Medicine, College of Medicine, University of Jeddah, Jeddah, SAU
| |
Collapse
|
8
|
Alghamdi W, Lotfy K, Weernink C, Alsolami E, Jevnikar A, Luke P, Skaro A, Qumosani K, Brahmania M, Marotta P, Hosseini-Moghaddam SM, Teriaky A. Hepatitis C positive organ transplantation to negative recipients at a multiorgan Canadian transplant centre: ready for prime time. BMC Gastroenterol 2022; 22:34. [PMID: 35078405 PMCID: PMC8787881 DOI: 10.1186/s12876-022-02107-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Accepted: 01/13/2022] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Transplantation offers the best survival for patients with end stage organ disease. Transplant of hepatitis C virus (HCV) nucleic acid test (NAT) positive organs into negative recipients is a novel strategy that can expand the donor pool. We aim to evaluate our centre's experience. METHODS We preformed a retrospective review of anti-HCV NAT positive and negative organs into negative recipients transplanted over 27 months. Primary outcome was the success rate of eradication of HCV post-transplant. Secondary outcomes were rate of transmission of HCV, treatment adverse events, and graft failure. RESULTS 33 anti-HCV positive organs were transplanted into negative recipients. 22 (66.7%) were NAT positive. Median recipients age was 49 years (interquartile range [IQR] 44.5-62.0) with the majority being males (57.6%). NAT positive organ transplantations included 16 kidneys, 3 livers, 1 kidney-pancreas, 1 liver-kidney, and 1 heart. The most common HCV genotype was 1a (59.1%). The median time to initiating therapy was 41.5 days. SVR12 was 100% in patients who finished therapy. There were no adverse events with therapy and no graft failure. CONCLUSIONS Anti-HCV NAT positive organ transplantation into negative recipients is safe with excellent eradication rates and no significant adverse events or graft failure. This would expand donor pool to close the gap between supply and demand.
Collapse
Affiliation(s)
- Waleed Alghamdi
- Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada.
- Division of Gastroenterology, Department of Medicine, King Abdulaziz University, Building 10, Second Floor, P.O. Box 55603, Jeddah, 21544, Saudi Arabia.
| | - Khaled Lotfy
- Division of Nephrology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Corinne Weernink
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Enad Alsolami
- Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Anthony Jevnikar
- Division of Nephrology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Patrick Luke
- Department of Surgery, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Anton Skaro
- Department of Surgery, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Karim Qumosani
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Mayur Brahmania
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Paul Marotta
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Syed M Hosseini-Moghaddam
- Division of Infectious Diseases, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| | - Anouar Teriaky
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada
- Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada
| |
Collapse
|
9
|
Alobaidi S, Dwid N, Salem N, Mehdawi F, Kashgary A, Alhozali H, Nablawi R, Alsolami E, Shaheen F, Akl A. Barriers to Kidney Transplantation among Adults on Maintenance Dialysis in Western Region Saudi Arabia: A Cross-Sectional Study. Saudi J Kidney Dis Transpl 2021; 32:49-59. [PMID: 34145114 DOI: 10.4103/1319-2442.318548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease. However, in Saudi Arabia, KT accounts for only 4.5% of the total existing renal replacement therapies in 2016. This cross-sectional study was conducted from September 2017 to January 2018. The aim was to assess the main barriers to the low KT rate in the Saudi community. Data were obtained by direct interviewing using a specifically pre-coded and pre-tested online questionnaire. A total of 321 adult hemodialysis and peritoneal dialysis (PD) (hemodialysis and PD, respectively) patients eligible for KT were selected from several dialysis units in Jeddah, accounting for 11% of the total dialysis population in Jeddah. The mean age was 49.9 ± 14.9 years, and 62.1% were male. Twenty-six percent were employed, and 88.2% were Saudis. Of those interviewed, 90.7% had been counseled for KT mostly by the nephrologist (86.5%) and 178 (55.5%) were referred for pre-transplant evaluation and 92 (28.6 %) were on the active transplant list. The most common barriers were lack of donor availability for 107 patients (40.5%), 58 patients (22%) worried about long-term complications, and 24 (9.1%) worried about surgical complications. Only 17 patients (6.4 %) reported financial constraints as the main reason for not having a KT, especially in non-Saudi patients. Additional initiatives to promote and improve the education and knowledge about kidney donation and the current outcome of KT is needed to improve the transplant rate in the country.
Collapse
Affiliation(s)
- Sami Alobaidi
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Naji Dwid
- Department of Internal Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
| | - Nada Salem
- Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Fahtima Mehdawi
- Department of Internal Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
| | - Abdullah Kashgary
- Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Hanadi Alhozali
- Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Rana Nablawi
- Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
| | - Enad Alsolami
- Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia
| | - Faissal Shaheen
- Department of Internal Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
| | - Ahmed Akl
- Department of Internal Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia; Urology and Nephrology Center, Mansoura University, Mansoura, Egypt; Department of Internal Medicine, Fakeeh College of Medical Sciences, Jeddah, Saudi Arabia
| |
Collapse
|